For dedifferentiated NENs, new molecular targets such as the CXCR4 and the CCK2 receptors have been assessed, the latter showing intriguing data for the staging of MTC using the targeting ligand minigastrin. Here, CXCR4 is linked to medullary thyroid gland carcinoma.